Guardian Pharmacy Services
GRDN
40.68
-0.52
-1.26%
Guardian Pharmacy Services
US · GRDN
#2584 by market cap
Listed 2024
40.68
-0.52
-1.26%
Live - 5344 symbols - heartbeat 141s ago
· 2026-10-08 07:14
Pre-market
40.68
0.00%
After-hours
40.68
0.00%
- Market cap
- 2.58B
- P/E (TTM)i
- 39.12
- P/Bi
- 10.49
- EPSi
- 0.78
- Div yieldi
- 0.00%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on GRDN?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 4 analysts
Buy
Avg price target
49.75 +22.3%
Price target rangecurrent 40.68
Low47.00
Avg49.75
High52.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-22 | KeyBanc | -- | BUY | 52.00 |
| 2026-09-21 | Truist Financial | -- | BUY | 51.00 |
| 2026-09-01 | BofA Securities | -- | BUY | 47.00 |
| 2026-08-07 | BofA Securities | -- | BUY | 47.00 |
| 2026-08-07 | Truist Financial | -- | BUY | -- |
| 2026-08-07 | Oppenheimer | -- | BUY | 49.00 |
| 2026-07-02 | BofA Securities | -- | BUY | -- |
| 2026-06-23 | BofA Securities | -- | BUY | -- |
| 2026-06-22 | Truist Financial | -- | BUY | 47.00 |
| 2026-06-17 | BofA Securities | -- | BUY | 47.00 |
| 2026-06-15 | Jefferies | -- | BUY | 50.00 |
| 2026-05-07 | BofA Securities | -- | BUY | 42.00 |
| 2026-05-07 | Oppenheimer | -- | BUY | 43.00 |
| 2026-04-27 | BofA Securities | -- | BUY | 42.00 |
| 2026-03-30 | Jefferies | -- | BUY | 44.00 |
| 2026-03-20 | Oppenheimer | -- | BUY | -- |
| 2026-03-12 | Truist Financial | -- | BUY | 38.00 |
| 2026-03-12 | Oppenheimer | -- | BUY | 38.00 |
| 2026-01-22 | Oppenheimer | -- | BUY | 35.00 |
| 2026-01-14 | Truist Financial | -- | BUY | -- |
| 2026-01-14 | Stephens | -- | BUY | 36.00 |
| 2025-11-18 | Oppenheimer | -- | BUY | 35.00 |
| 2025-11-14 | Truist Financial | -- | BUY | 34.00 |
| 2025-11-11 | Truist Financial | -- | BUY | -- |
| 2025-11-11 | Oppenheimer | -- | BUY | 35.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±13.25% | +11.05% (in line) |
| 2026/Q1 | 2026-05-06 | After close | ±12.74% | -0.85% (in line) |
| 2025/Q4 | 2026-03-11 | After close | ±13.18% | -0.72% (in line) |
| 2025/Q3 | 2025-11-10 | After close | -- | +5.04% |
| 2025/Q2 | 2025-08-11 | After close | -- | +13.78% |
| 2025/Q1 | 2025-05-12 | After close | -- | -3.98% |
| 2024/Q4 | 2025-03-26 | After close | -- | +4.35% |
| 2024/Q3 | 2024-11-12 | After close | -- | -10.73% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:14:49 · For reference only, not investment advice and not tailored to your situation.